DIABETIC RETINOPATHY MARKET ANALYSIS

Key Takeaways from Analyst

The global diabetic retinopathy market is expected to witness significant growth over the forecast period owing to the rising prevalence of diabetes around the world. North America will continue to dominate the market due to growing awareness levels and availability of advanced treatment options in the region. However, Asia Pacific is likely to emerge as the fastest growing market due to the rising geriatric population and growing cases of diabetes in countries like India and China.

One of the major drivers for the market is the increasing number of FDA approvals for novel drugs and devices for the treatment of different stages of diabetic retinopathy. Moreover, the development of affordable anti-VEGF drugs for treating proliferative diabetic retinopathy will provide opportunities for market expansion in middle-income countries. However, lack of awareness about early symptoms of DR in low-income nations is a major challenge for the industry.

Research indicates that market players should focus on developing cost-effective screening technologies to increase early detection rates. They must also conduct awareness programs in developing nations to educate people about eye examination benefits. Collaboration with government bodies can aid screening programs across rural areas. Accumulating clinical data for pipeline drugs will help in quickly obtaining regulatory approvals as well.